Invasive breast carcinoma - IARC

52. Akhtar M, Robinson C, Ashraf Ali M,
Godwin JT (1983). Secretory carcinoma of
the breast in adults. Cancer 51: 2245-2254.
53. Akiyama Y, Sato H, Yamada T, Nagasaki
H, Tsuchiya A, Abe R, Yuasa Y (1997).
Germ-line mutation of the hMSH6/GTBP
gene in an atypical hereditary nonpolyposis
colorectal cancer kindred. Cancer Res
57: 3920-3923.
54. Al Jafari MS, Panton HM, Gradwell E
(1985). Phaeochromocytoma of the broad
ligament. Case report. Br J Obstet
Gynaecol 92: 649-651.
5 5 . Al Kurdi M, Monaghan JM (1981).
Thirty-two years experience in management
of primary tumours of the vagina. Br
J Obstet Gynaecol 88: 1145-1150.
56. Al Nafussi AI, Al Yusif R (1998). Papillary
squamotransitional cell carcinoma of the
uterine cervix: an advanced stage disease
despite superficial location: report of two
cases and review of the literature. Eur J
Gynaecol Oncol 19: 455-457.
5 7 . Al Nafussi AI, Hughes DE (1994).
Histological features of CIN3 and their
value in predicting invasive microinvasive
squamous carcinoma. J Clin Pathol 47:
799-804.
5 8 . Alamowitch B, Mausset V, Ruiz A,
Tissier F, Fourmestraux J, Bouillot JL,
Bethoux JP (1999). [Non-secreting
pheochromocytoma of the broad ligament
revealed by appendicular peritonitis].
Presse Med 28: 225-228.
59. Albain KS, Allred DC, Clark GM (1994).
Breast cancer outcome and predictors of
outcome: are there age differentials? J
Natl Cancer Inst Monogr 35-42.
60. Albertson DG, Ylstra B, Segraves R,
Collins C, Dairkee SH, Kowbel D, Kuo WL,
Gray JW, Pinkel D (2000). Quantitative
mapping of amplicon structure by array
CGH identifies CYP24 as a candidate oncogene.
Nat Genet 25: 144-146.
6 1 . Albonico G, Querzoli P, Ferretti S,
Rinaldi R, Nenci I (1996). Biological heterogeneity
of breast carcinoma in situ. Ann N
Y Acad Sci 784: 458-461.
6 2 . Albonico G, Querzoli P, Ferretti S,
Rinaldi R, Nenci I (1998). Biological profile
of in situ breast cancer investigated by
immunohistochemical technique. Cancer
Detect Prev 22: 313-318.
6 3 . Albores-Saavedra J, Gersell D, Gilks
CB, Henson DE, Lindberg G, Santiago H,
Scully RE, Silva E, Sobin LH, Tavassoli FJ,
Travis WD, Woodruff JM (1997).
Terminology of endocrine tumors of the
uterine cervix: results of a workshop
sponsored by the College of American
Pathologists and the National Cancer
I n s t i t u t e . Arch Pathol Lab Med 121: 34-39.
6 4 . Albores-Saavedra J, Gilcrease M
(1999). Glomus tumor of the uterine cervix.
Int J Gynecol Pathol 18: 69-72.
65. Albores-Saavedra J, Manivel C, Mora
A, Vuitch F, Milchgrub S, Gould E (1992).
The solid variant of adenoid cystic carcinoma
of the cervix.Int J Gynecol Pathol11:
2-10.
66. Albores-Saavedra J, Young RH (1995).
Transitional cell neoplasms (carcinomas
and inverted papillomas) of the uterine
cervix. A report of five cases. Am J Surg
Pathol 19: 1138-1145.
67. Alderson MR, Hamlin I, Staunton MD
(1971). The relative significance of prognostic
factors in breast carcinoma. Br J
Cancer 25: 646-656.
68. Alfsen GC, Kristensen GB, Skovlund E,
Pettersen EO, Abeler VM (2001). Histologic
subtype has minor importance for overall
survival in patients with adenocarcinoma
of the uterine cervix: a population-based
study of prognostic factors in 505 patients
with nonsquamous cell carcinomas of the
cervix. Cancer 92: 2471-2483.
69 . Alizadeh AA, Ross DT, Perou CM, van de
Rijn M (2001). Towards a novel classification
of human malignancies based on gene
expression patterns. J Pathol 195: 41-52.
70 . Allaire AD, Majmudar B (1993).
Dracunculosis of the broad ligament. A
case of a "parasitic leiomyoma". Am J Surg
Pathol 17: 937-940.
71. Allred DC, Elledge RM (1999). Caution
concerning micrometastatic breast carcinoma
in sentinel lymph nodes. Cancer 86:
905-907.
72. Allred DC, Mohsin SK, Fuqua SA (2001).
Histological and biological evolution of
human premalignant breast disease.
Endocr Relat Cancer 8: 47-61.
73 . Altaras MM, Jaffe R, Corduba M,
Holtzinger M, Bahary C (1990). Primary
paraovarian cystadenocarcinoma: clinical
and management aspects and literature
review. Gynecol Oncol 38: 268-272.
74 . Alvarado-Cabrero I, Navani SS, Young
RH, Scully RE (1997). Tumors of the fimbriated
end of the fallopian tube: a clinicopathologic
analysis of 20 cases, including nine carcinom
a s .Int J Gynecol Pathol 16: 189-196.
75 . Alvarado-Cabrero I, Young RH,
Vamvakas EC, Scully RE (1999). Carcinoma
of the fallopian tube: a clinicopathological
study of 105 cases with observations on
staging and prognostic factors. Gynecol
Oncol 72: 367-379.
76 . Alvarez-Fernandez E, Salinero-
Paniagua E (1981). Vascular tumors of the
mammary gland. A histochemical and
ultrastructural study. Virchows Arch A
Pathol Anat Histol 394: 31-47.
77. Amant F, Moerman P, Davel GH, De Vos
R, Vergote I, Lindeque BG, de Jonge E
(2001). Uterine carcinosarcoma with
melanocytic differentiation. Int J Gynecol
Pathol 20: 186-190.
78 . Ambros RA, Kurman RJ (1992).
Combined assessment of vascular and
myometrial invasion as a model to predict
prognosis in stage I endometrioid adenocarcinoma
of the uterine corpus. Cancer
69: 1424-1431.
79. Ambros RA, Sherman ME, Zahn CM,
Bitterman P, Kurman RJ (1995).
Endometrial intraepithelial carcinoma: a
distinctive lesion specifically associated
with tumors displaying serous differentiation.
Hum Pathol 26: 1260-1267.
80. American Joint Committee on Cancer
(1997). AJCC Cancer Staging Manual. 5th
ed. Lippincott-Raven: Philadelphia.
81. Amr SS, Elmallah KO (1995). Agressive
angiomyxoma of the vagina. Int J
Gynaecol Obstet 42: 207-210.
82 . Anan K, Mitsuyama S, Tamae K,
Nishihara K, Iwashita T, Abe Y, Ihara T,
Nakahara S, Katsumoto F, Toyoshima S
(2001). Pathological features of mucinous
carcinoma of the breast are favourable for
breast-conserving therapy. Eur J Surg
Oncol 27: 459-463.
83 . Anand S, Penrhyn-Lowe S,
Venkitaraman AR (2003). AURORA-A amplification
overrides the mitotic spindle
assembly checkpoint, inducing resistance
to Taxol. Cancer Cell 3: 51-62.
8 4 . Anastassiades OT, Bouropoulou V,
Kontogeorgos G, Tsakraklides EV (1979).
Duct elastosis in infiltrating carcinoma of
the breast. Pathol Res Pract 165: 411-421.
85. Anbazhagan R, Fujii H, Gabrielson E
(1999). Microsatellite instability is uncommon
in breast cancer. Clin Cancer Res 5:
839-844.
86. Andersen JA (1974). Lobular carcinoma
in situ of the breast with ductal involvement.
Frequency and possible influence on
prognosis. Acta Pathol Microbiol Scand
[A] 82: 655-662. 87. Andersen JA (1974).
Lobular carcinoma in situ. A histologic
study of 52 cases. Acta Pathol Microbiol
Scand [A] 82: 735-741.
88. Andersen JA (1974). Lobular carcinoma
in situ. A long-term follow-up in 52 cases.
Acta Pathol Microbiol Scand [A] 82: 519-
533.
89. Andersen JA, Vendelboe ML (1981).
Cytoplasmic mucous globules in lobular
carcinoma in situ. Diagnosis and prognosis.
Am J Surg Pathol 5: 251-255.
9 0 . Anderson B, Turner DA, Benda J (1987).
Ovarian sarcoma. Gynecol Oncol 26: 183-192.
9 1 . Anderson BO, Petrek JA, Byrd DR,
Senie RT, Borgen PI (1996). Pregnancy
influences breast cancer stage at diagnosis
in women 30 years of age and younger.
Ann Surg Oncol 3: 204-211.
92. Anderson C, Ricci A Jr., Pedersen CA,
Cartun RW (1991). Immunocytochemical
analysis of estrogen and progesterone
receptors in benign stromal lesions of the
breast. Evidence for hormonal etiology in
pseudoangiomatous hyperplasia of mammary
stroma. Am J Surg Pathol 15: 145-149.
92a. Anderson DE (1971). Some characteristics
of familial breast cancer. Cancer 28:
1500-1504.
93. Anderson DE (1974). Genetic study of
breast cancer: identification of a high risk
group. Cancer 34: 1090-1097.
9 4 . Anderson DE, Badzioch MD (1992).
Breast cancer risks in relatives of male
breast cancer patients. J Natl Cancer Inst
84: 1114-1117.
9 5 . Anderson DE, Badzioch MD (1993).
Familial effects of prostate and other cancers
on lifetime breast cancer risk. Breast
Cancer Res Treat 28: 107-113.
9 6 . Anderson MC, Rees DA (1975).
Gynandroblastoma of the ovary. Br J
Obstet Gynaecol 82: 68-73.
9 7 . Anderson TJ, Lamb J, Donnan P,
Alexander FE, Huggins A, Muir BB,
Kirkpatrick AE, Chetty U, Hepburn W, Smith
A, Prescott RJ, Forrest P. (1991).
Comparative pathology of breast cancer in
a randomised trial of screening. Br J
Cancer 64: 108-113.
98. Andrac-Meyer L, Solere K, Sappa P,
Garcia S, Charpin C (2000). [Infiltrating
syringoadenoma of the nipple: a new
case]. Ann Pathol 20: 142-144.
99. Andrassy RJ, Wiener ES, Raney RB,
Hays DM, Arndt CA, Lobe TE, Lawrence W,
Anderson JR, Qualman SJ, Crist WM
(1999). Progress in the surgical management
of vaginal rhabdomyosarcoma: a 25-
year review from the Intergroup
Rhabdomyosarcoma Study Group. J
Pediatr Surg 34: 731-734.
100. Andreasson B, Bock JE, Strom KV,
Visfeldt J (1983). Verrucous carcinoma of
the vulval region. Acta Obstet Gynecol
Scand 62: 183-186.
101 . Angele S, Lauge A, Fernet M, Moullan
N, Beauvais P, Couturier J, Stoppa-Lyonnet
D, Hall J (2003). Phenotypic cellular characterization
of an ataxia telangiectasia
patient carrying a causal homozygous missense
mutation. Hum Mutat 21: 169-170.
102 . Angele S, Treilleux I, Taniere P,
Martel-Planche G, Vuillaume M, Bailly C,
Bremond A, Montesano R, Hall J (2000).
Abnormal expression of the ATM and TP53
genes in sporadic breast carcinomas. Clin
Cancer Res 6: 3536-3544.
103. Ansah-Boateng Y, Wells M, Poole DR
(1985). Coexistent immature teratoma of
the uterus and endometrial adenocarcino -
ma complicated by gliomatosis peritonei.
Gynecol Oncol 21: 106-110.
104 . Anteby EY, Ron M, Revel A,
Shimonovitz S, Ariel I, Hurwitz A (1994).
Germ cell tumors of the ovary arising after
dermoid cyst resection: a long-term follow-up
study. Obstet Gynecol 83: 605-608.
105 . Anthony PP, James PD (1975).
Adenoid cystic carcinoma of the breast:
prevalence, diagnostic criteria, and histogenesis.
J Clin Pathol 28: 647-655.
106. Antoniou A, Pharoah PD, Narod S,
Risch HA, Eyfjord JE, Hopper JL, Loman N,
Olsson H, Johannsson O, Borg A, Pasini B,
Radice P, Manoukian S, Eccles DM, Tang
N, Olah E, Anton-Culver H, Warner E,
Lubinski J, Gronwald J, Gorski B, Tulinius
H, Thorlacius S, Eerola H, Nevanlinna H,
Syrjakoski K, Kallioniemi OP, Thompson D,
Evans C, Peto J, Lalloo F, Evans DG, Easton
DF (2003). Average risks of breast and
ovarian cancer associated with BRCA1 or
BRCA2 mutations detected in case series
unselected for family history: a combined
analysis of 22 studies. Am J Hum Genet 72:
1117-1130.
107. Antoniou AC, Pharoah PD, McMullan
G, Day NE, Ponder BA, Easton D (2001).
Evidence for further breast cancer susceptibility
genes in addition to BRCA1 and
BRCA2 in a population-based study. Genet
Epidemiol 21: 1-18.
108. Anttila T, Saikku P, Koskela P, Bloigu
A, Dillner J, Ikaheimo I, Jellum E, Lehtinen
M, Lenner P, Hakulinen T, Narvanen A,
Pukkala E, Thoresen S, Youngman L,
Paavonen J (2001). Serotypes of Chlamydia
trachomatis and risk for development of
cervical squamous cell carcinoma. JAMA
285: 47-51.
109. Anzick SL, Kononen J, Walker RL,
Azorsa DO, Tanner MM, Guan XY, Sauter
G, Kallioniemi OP, Trent JM, Meltzer PS
(1997). AIB1, a steroid receptor coactivator
amplified in breast and ovarian cancer.
Science 277: 965-968.
110. Aoyama C, Peters J, Senadheera S,
Liu P, Shimada H (1998). Uterine cervical
dysplasia and cancer: identification of c-
myc status by quantitative polymerase
chain reaction. Diagn Mol Pathol 7: 324-
330.
111. Aoyama T, Mizuno T, Andoh K, Takagi
T, Mizuno T, Eimoto T (1996). alpha-
Fetoprotein-producing (hepatoid) carcinoma
of the fallopian tube. Gynecol Oncol 63:
261-266.
112 . Aozasa K, Ito H, Kohro T, Ha K,
Nakamura M, Okada A (1981). Chorio-carcinoma
in infant and mother. Acta Pathol
Jpn 31: 317-322.
113 . Aozasa K, Ohsawa M, Saeki K,
Horiuchi K, Kawano K, Taguchi T (1992).
Malignant lymphoma of the breast.
Immunologic type and association with
lymphocytic mastopathy. Am J Clin Pathol
97: 699-704.
References 373